Quantum Biopharma (QNTM) Interest Coverage Ratio (2019 - 2026)
Quantum Biopharma recorded quarterly Interest Coverage Ratio of 129.79 in Q1 2026, down 764.4% quarter-over-quarter from 15.02 in Q4 2025, and up 15.31% year-over-year from 112.56 in Q1 2025.
Quantum Biopharma's Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 129.79 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 15.31% year-over-year to 129.79; the TTM figure through Mar 2026 stood at 38.19 (up 87.56% YoY), while the FY2025 annual figure was 96.81, up 80.19% from the prior year.
- Interest Coverage Ratio came in at 129.79 for Q1 2026 at Quantum Biopharma, down from 15.02 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 344.97 in Q4 2023 to a low of 14760.08 in Q1 2023.
- A 5-year average of 1287.4 and a median of 153.26 in 2025 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio sank 4379.89% in 2023 and soared 98.77% in 2024, its largest moves.
- Quantum Biopharma's Interest Coverage Ratio stood at 344.87 in 2022, then climbed by 0.03% to 344.97 in 2023, then sank by 423.34% to 1115.43 in 2024, then surged by 98.65% to 15.02 in 2025, then tumbled by 764.4% to 129.79 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 129.79, 15.02, and 51.09 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -36.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129.79 |
| Dec 31, 2025 | 32.67 |
| Sep 30, 2025 | -51.09 |
| Jun 30, 2025 | -41.50 |
| Mar 31, 2025 | -133.89 |
| Dec 31, 2024 | -1,115.43 |
| Sep 30, 2024 | -403.15 |
| Jun 30, 2024 | -413.62 |
| Mar 31, 2024 | -181.84 |
| Dec 31, 2023 | 344.97 |
| Sep 30, 2023 | -161.29 |
| Mar 31, 2023 | -4,148.75 |
| Mar 31, 2022 | 288.03 |
| Jun 30, 2021 | -670.79 |
| Mar 31, 2021 | 507.25 |
| Sep 30, 2020 | -215.74 |
| Jun 30, 2020 | -70.52 |
| Mar 31, 2020 | -91.37 |
| Dec 31, 2019 | -137.41 |